New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
-
SSM Health Kidney Care begins serving patients in the St. Louis community
-
DataRobot Unveils Latest Version of Enterprise AI Platform, Introducing Visual AI, AI Applications, and Automated Deep Learning
-
OmniSci Announces Expansion to Address Growing Demand in Asia, Adds Joseph Lee as Vice President, Global Sales
-
Form SC 13D LUMOS PHARMA, INC. Filed by: New Enterprise Associates 14, L.P.
-
Tom Reilly, Former CEO of Cloudera and ArcSight, Joins OmniSci Board of Advisors
-
OrphoMed Pauses Recruitment for Phase 2 Adaptive Design Study of ORP-101 for Treatment of IBS-D
-
Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies
-
Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies
-
Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board
-
Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board
-
CIT Recognizes Women-Led Virginia Startups During Women’s History Month
-
GigSmart Launches Health Marketplace to Provide Benefits to Independent Workers
-
CIT GAP Funds Invests in MetiStream to Improve Patient Outcomes by Addressing Healthcare Industry’s Unstructured Data Problems
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
-
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
-
Form SC 13D IMARA Inc. Filed by: New Enterprise Associates 14, L.P.
-
DataRobot Opens Up its Platform for COVID-19 Response Efforts
-
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
-
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
-
Topia Acquires Monaeo
-
CarAdvise & Stride Partner to Drive More Value in the Gig-Economy and Beyond
-
NEA Closes On $3.6B for New Fund with Focus on Early-Stage Technology and Healthcare Investments
-
2019 Full-Year Results: Significant progress in NASH, MPS VI and psoriasis, and extended cash runway
-
2019 Full-Year Results: Significant progress in NASH, MPS VI and psoriasis, and extended cash runway
-
Trillium Therapeutics Reports Annual Financial and Operating Results
-
Industry Experts Join Forces to Analyze Corporate Use Cases and Returns on Artificial Intelligence
-
Pager Announces $33M Financing Round
-
DataRobot and InterSystems Partner to Accelerate Adoption of AI in Healthcare
-
CTI BioPharma Announces Closing of Rights Offering
-
Akouos Closes $105 Million Series B Financing
-
First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
-
First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
-
Topia Introduces Industry-First Global Talent Mobility Assessment Framework
-
StreamSets Expands Databricks Partnership extending ingestion capabilities for Delta Lake
-
ICER and Aetion partner to develop real-world evidence for value assessment of treatments
-
Form SC 13D Casper Sleep Inc. Filed by: New Enterprise Associates 14, L.P.
-
DataRobot Named a Visionary in the 2020 Gartner Magic Quadrant for Data Science and Machine Learning Platforms
-
OrphoMed to Present Phase 1 Results of ORP-101 at Digestive Disease Week 2020
-
DataRobot Unveils New Snowflake Integration to Streamline and Simplify AI
-
CTI BioPharma Announces Commencement of Rights Offering
-
Form SC 13D Black Diamond Therapeuti Filed by: New Enterprise Associates 16, L.P.
-
Form SC 13G/A MongoDB, Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G/A Surface Oncology, Inc. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G Galera Therapeutics, Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G Sprout Social, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A Elastic N.V. Filed by: New Enterprise Associates 14, L.P.
-
Form SC 13G Cloudflare, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13G/A Bloom Energy Corp Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Sentry Application Monitoring Achieves 200% Increase in Enterprise Growth Scaling to a Total of 18K+ Paid Customers

